Page 63 - 2018食藥署年報(英文版)

04 Drugs and Prevention of Drug Abuse

Reinforced Management of Controlled

For addictive narcotics and substances with psychotic effects and their products, there is
the “Narcotics Hazard Prevention Act” in our country to strictly govern their use. Those with
medical or scientific research value, however, are listed as controlled drugs. To effectively govern
the reasonable use of controlled drugs and to prevent against drug abuse, the Administration
established the drug abuse monitoring mechanism that helps with an understanding of the trends
of drug abuse in our country and the evaluation of new psychoactive substances (NPS) that have
been abused internationally or recently. We also provide the Ministry of Justice with advice on

the addition and revision of items listed as controlled at the same time. In addition, to reinforce
the management of controlled drugs, when it is necessary to use NPS that are newly included in
the controlled list by the Ministry of Justice over the past few years to fulfill scientific needs, such
drugs will be regulated as controlled drugs in order to prevent unjustified usage or abuse that is
hazardous to national health.
The Administration has cooperated with Executive Yuan to promote “New-generation Anti-
drug Strategy” for the general public to get an understanding of the government’s determination

to and the action it has taken to fight against drug abuse, the Administration set up the “New-
generation Anti-drug Strategy” section on its official website to periodically provide the latest
information on drug testing, monitoring, analysis, and drug hazards and also to educate people on
staying away from drugs. Meanwhile, the anti-drug hackathon competition had all the experts in
civil to brainstorm and come up with anti-drug technological and digital services.

Section 1 Assessment and Addition of Regulated
Controlled Drugs Products

Origin of Policy

In order to eradicate abuse or illegal use of controlled drugs, according to the “Controlled

Drugs Act,” the Ministry of Health and Welfare set up the “MOHW Controlled Drug Review
Committee” to perform classified and itemized reviews reflective of the habits, dependency,
extent of abuse, and hazards to society associated with controlled drugs and report the results to
the Executive Yuan for approval and announcement.

61